In the CROSS trial, which evaluated neoadjuvant chemoradiotherapy plus surgery versus surgery alone for resectable esophageal or GE junction cancer, what were the RO resection and pCR rates?
In the CROSS trial, which evaluated neoadjuvant chemoradiotherapy plus surgery versus surgery alone for resectable esophageal or GE junction cancer, what were the RO resection and pCR rates?